Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3′ untranslated region

Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3′ untranslated region

The transcription factor ONECUT2 (OC2) is a master transcriptional regulator operating in metastatic castration-resistant prostate cancer that suppresses androgen receptor activity and promotes neural differentiation and tumor cell survival. OC2 mRNA possesses an unusually long (14,575 nt), evolutio...

Full description

Bibliographic Details
Main Authors:	Kenneth Steadman, Sungyong You, Dustin V. Srinivas, Lila Mouakkad, Yiwu Yan, Minhyung Kim, Smrruthi V. Venugopal, Hisashi Tanaka, Michael R. Freeman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	competitive endogenous RNA network neuroendocrine prostate cancer polycomb repressing complex androgen metabolism prostate cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2023.1206259/full

Similar Items

PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells
by: Payal Jain, et al.
Published: (2020-03-01)

Novel Insights on the Role of Epigenetics in Androgen Receptor’s Expression in Prostate Cancer
by: Vânia Camilo, et al.
Published: (2023-10-01)

Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment
by: Tomoyuki Makino, et al.
Published: (2021-04-01)

Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01)

Expression of Androgen Receptor Is Negatively Regulated By p53
by: Fatouma Alimirah, et al.
Published: (2007-12-01)

Long non-coding RNAs in castration-resistant and neuroendocrine prostate cancer: Potential role and therapeutic impact
by: Kumari S. Prajapati, et al.
Published: (2020-12-01)

Androgen Receptor Roles in Benign and Malignant Prostate Disease
Published: (2011-06-01)

Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
by: Ruopeng Su, et al.
Published: (2022-08-01)

Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
by: Lina Merkens, et al.
Published: (2022-02-01)

Titration of Androgen Signaling: How Basic Studies Have Informed Clinical Trials Using High-Dose Testosterone Therapy in Castrate-Resistant Prostate Cancer
by: Steven K. Nordeen, et al.
Published: (2021-08-01)

Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [<sup>68</sup>Ga]Ga DOTATATE PET-CT
by: Mehmet Asim Bilen, et al.
Published: (2022-12-01)

Gross Findings of Widespread Visceral Metastasis of Prostatic Adenocarcinoma With Neuroendocrine Features: A Case Report
by: David J. Habibian, et al.
Published: (2016-09-01)

Targeting neuroendocrine prostate cancer: molecular and clinical perspectives
by: Panagiotis J Vlachostergios, et al.
Published: (2015-02-01)

Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
by: Rittu Hingorani, et al.
Published: (2014-11-01)

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
by: Emre Yekedüz, et al.
Published: (2021-03-01)

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
by: Renée de Leeuw, et al.
Published: (2020-10-01)

Regulatory genes in the androgen production, uptake and conversion (APUC) pathway in advanced prostate cancer
by: Sean McSweeney, et al.
Published: (2023-01-01)

Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
by: Wen-Chi Cheng, et al.
Published: (2021-01-01)

Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
by: Takashi Ando, et al.
Published: (2020-07-01)

Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
by: Sirin Saranyutanon, et al.
Published: (2019-12-01)

A rare primary large-cell neuroendocrine carcinoma of the prostate: A case report
by: Yifeng Li, et al.
Published: (2023-09-01)

Mechanisms of castration resistant prostate cancer formation and progression through neuroendocrine differentiation
by: Xueping Ma, et al.
Published: (2021-09-01)

Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
by: Éva Erdmann, et al.
Published: (2022-07-01)

Neuroendocrine differentiation in prostate cancer – a review
by: R. Popescu, et al.
Published: (2015-12-01)

Neuroendocrine aspects of prostate oncogenesis
by: P.V. Glybochko, et al.
Published: (2010-03-01)

Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants
by: Demitria M. Vasilatis, et al.
Published: (2023-04-01)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
by: Rodolfo Montironi, et al.
Published: (2020-04-01)

Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate cancer
by: Hengfeng Zhou, et al.
Published: (2022-07-01)

Polycomb-like Proteins in Gene Regulation and Cancer
by: Sabrina Fischer, et al.
Published: (2023-04-01)

Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study
by: YouZhi Wang, et al.
Published: (2022-09-01)

Polycomb Directed Cell Fate Decisions in Development and Cancer
by: Beatriz German, et al.
Published: (2022-09-01)

The Current Therapeutic Landscape for Metastatic Prostate Cancer
by: Anastasia Bernal, et al.
Published: (2024-03-01)

Emerging role of transforming growth factor-β-regulated long non-coding RNAs in prostate cancer pathogenesis
by: Bakhya Shree, et al.
Published: (2023-07-01)

Neuroendocrine and Aggressive-Variant Prostate Cancer
by: Nicholas Spetsieris, et al.
Published: (2020-12-01)

Expression of Fibroblast Activation Protein Is Enriched in Neuroendocrine Prostate Cancer and Predicts Worse Survival
by: Panagiotis J. Vlachostergios, et al.
Published: (2022-01-01)

The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity
by: William K. Storck, et al.
Published: (2022-07-01)

Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression
by: Roosa Kaarijärvi, et al.
Published: (2021-02-01)

Stromal Androgen Receptor in Prostate Cancer Development and Progression
by: Damien A. Leach, et al.
Published: (2017-01-01)

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation
by: Heikki Seikkula, et al.
Published: (2020-03-01)

Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population
by: Gao M, et al.
Published: (2023-07-01)